Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381512019> ?p ?o ?g. }
- W4381512019 endingPage "77" @default.
- W4381512019 startingPage "69" @default.
- W4381512019 abstract "Background: Migraine is a widespread neurological disorder that can impair quality of life. Current treatments are often insufficient, with side effects causing some patients to seek alternative options. Zavegepant nasal spray, a new treatment being developed for acute migraine, shows promise in blocking the CGRP receptor and providing several potential advantages, such as faster onset of action and higher bioavailability. This systematic review aimed to assess the efficacy and safety of Zavegepant nasal spray in treating acute migraine attacks and identify adverse events.
 Methods: Adult patients diagnosed with acute migraine who were treated with Zavegepant nasal spray in randomized controlled trials (RCTs) or non-randomized clinical trials were included. A comprehensive search was conducted in PubMed, Embase, Cochrane Library, and ClinicalTrials.gov until March 2023. The following keywords were employed: Zavegepant nasal spray, migraine, calcitonin gene-related peptide receptor antagonist. A narrative synthesis was conducted to summarize and analyze the extracted data from the included studies, with a focus on the efficacy and safety of Zavegepant nasal spray for the treatment of acute migraine.
 Results: This systematic review included three clinical trials, of which two were RCTs, and one was an open-label trial. The total number of participants was 3681, and all of them were in phase 2/3 of testing. The inclusion criteria for these trials were broadly based on individuals who had a history of migraines with or without aura lasting for over a year, which is consistent with the third edition of the International Classification of Headache Disorder. The findings were tabulated and discussed.
 Conclusion: Zavegepant nasal spray is an effective and well-tolerated treatment for acute migraines. Further research is needed to confirm its safety and efficacy, optimal dosing and administration, and effectiveness in different populations. The cost-effectiveness, patient satisfaction, and long-term effects on migraine burden ought to be investigated." @default.
- W4381512019 created "2023-06-22" @default.
- W4381512019 creator A5003092182 @default.
- W4381512019 creator A5006135907 @default.
- W4381512019 creator A5038158569 @default.
- W4381512019 creator A5042931347 @default.
- W4381512019 creator A5051169186 @default.
- W4381512019 creator A5063542493 @default.
- W4381512019 creator A5067062518 @default.
- W4381512019 creator A5070362308 @default.
- W4381512019 creator A5092224630 @default.
- W4381512019 creator A5092224631 @default.
- W4381512019 creator A5092224632 @default.
- W4381512019 creator A5092224633 @default.
- W4381512019 creator A5092224634 @default.
- W4381512019 creator A5092224635 @default.
- W4381512019 creator A5092224636 @default.
- W4381512019 date "2023-06-21" @default.
- W4381512019 modified "2023-10-16" @default.
- W4381512019 title "Zavegepant Nasal Spray for Treatment of Acute Migraine: A Systematic Review" @default.
- W4381512019 doi "https://doi.org/10.9734/jammr/2023/v35i165090" @default.
- W4381512019 hasPublicationYear "2023" @default.
- W4381512019 type Work @default.
- W4381512019 citedByCount "0" @default.
- W4381512019 crossrefType "journal-article" @default.
- W4381512019 hasAuthorship W4381512019A5003092182 @default.
- W4381512019 hasAuthorship W4381512019A5006135907 @default.
- W4381512019 hasAuthorship W4381512019A5038158569 @default.
- W4381512019 hasAuthorship W4381512019A5042931347 @default.
- W4381512019 hasAuthorship W4381512019A5051169186 @default.
- W4381512019 hasAuthorship W4381512019A5063542493 @default.
- W4381512019 hasAuthorship W4381512019A5067062518 @default.
- W4381512019 hasAuthorship W4381512019A5070362308 @default.
- W4381512019 hasAuthorship W4381512019A5092224630 @default.
- W4381512019 hasAuthorship W4381512019A5092224631 @default.
- W4381512019 hasAuthorship W4381512019A5092224632 @default.
- W4381512019 hasAuthorship W4381512019A5092224633 @default.
- W4381512019 hasAuthorship W4381512019A5092224634 @default.
- W4381512019 hasAuthorship W4381512019A5092224635 @default.
- W4381512019 hasAuthorship W4381512019A5092224636 @default.
- W4381512019 hasBestOaLocation W43815120191 @default.
- W4381512019 hasConcept C118303440 @default.
- W4381512019 hasConcept C126322002 @default.
- W4381512019 hasConcept C163170386 @default.
- W4381512019 hasConcept C168563851 @default.
- W4381512019 hasConcept C170493617 @default.
- W4381512019 hasConcept C17744445 @default.
- W4381512019 hasConcept C189708586 @default.
- W4381512019 hasConcept C197934379 @default.
- W4381512019 hasConcept C199539241 @default.
- W4381512019 hasConcept C2776478404 @default.
- W4381512019 hasConcept C2778541695 @default.
- W4381512019 hasConcept C2778871607 @default.
- W4381512019 hasConcept C2778938600 @default.
- W4381512019 hasConcept C2779473830 @default.
- W4381512019 hasConcept C2780564907 @default.
- W4381512019 hasConcept C2780973058 @default.
- W4381512019 hasConcept C535046627 @default.
- W4381512019 hasConcept C71924100 @default.
- W4381512019 hasConcept C85663871 @default.
- W4381512019 hasConcept C98274493 @default.
- W4381512019 hasConceptScore W4381512019C118303440 @default.
- W4381512019 hasConceptScore W4381512019C126322002 @default.
- W4381512019 hasConceptScore W4381512019C163170386 @default.
- W4381512019 hasConceptScore W4381512019C168563851 @default.
- W4381512019 hasConceptScore W4381512019C170493617 @default.
- W4381512019 hasConceptScore W4381512019C17744445 @default.
- W4381512019 hasConceptScore W4381512019C189708586 @default.
- W4381512019 hasConceptScore W4381512019C197934379 @default.
- W4381512019 hasConceptScore W4381512019C199539241 @default.
- W4381512019 hasConceptScore W4381512019C2776478404 @default.
- W4381512019 hasConceptScore W4381512019C2778541695 @default.
- W4381512019 hasConceptScore W4381512019C2778871607 @default.
- W4381512019 hasConceptScore W4381512019C2778938600 @default.
- W4381512019 hasConceptScore W4381512019C2779473830 @default.
- W4381512019 hasConceptScore W4381512019C2780564907 @default.
- W4381512019 hasConceptScore W4381512019C2780973058 @default.
- W4381512019 hasConceptScore W4381512019C535046627 @default.
- W4381512019 hasConceptScore W4381512019C71924100 @default.
- W4381512019 hasConceptScore W4381512019C85663871 @default.
- W4381512019 hasConceptScore W4381512019C98274493 @default.
- W4381512019 hasIssue "16" @default.
- W4381512019 hasLocation W43815120191 @default.
- W4381512019 hasOpenAccess W4381512019 @default.
- W4381512019 hasPrimaryLocation W43815120191 @default.
- W4381512019 hasRelatedWork W2006390069 @default.
- W4381512019 hasRelatedWork W2106261382 @default.
- W4381512019 hasRelatedWork W2132805893 @default.
- W4381512019 hasRelatedWork W2156439264 @default.
- W4381512019 hasRelatedWork W2161792711 @default.
- W4381512019 hasRelatedWork W2792256483 @default.
- W4381512019 hasRelatedWork W3180685105 @default.
- W4381512019 hasRelatedWork W3198487993 @default.
- W4381512019 hasRelatedWork W4319170690 @default.
- W4381512019 hasRelatedWork W49157362 @default.
- W4381512019 hasVolume "35" @default.
- W4381512019 isParatext "false" @default.
- W4381512019 isRetracted "false" @default.